| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 29/03/2019 | 13h25 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 29/03/2019 | 11h09 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 27/03/2019 | 20h04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 27/03/2019 | 13h30 | GlobeNewswire Inc. | Pain Therapeutics Announces Name Change to Cassava Sciences, Inc. | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 25/03/2019 | 18h10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 25/03/2019 | 13h30 | GlobeNewswire Inc. | Pain Therapeutics Reports 2018 Financial Results and Corporate Update | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 22/03/2019 | 21h10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 04/03/2019 | 20h56 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 14/02/2019 | 21h04 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 14/02/2019 | 19h47 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 13/02/2019 | 22h36 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 11/02/2019 | 22h48 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 08/02/2019 | 22h06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 08/02/2019 | 19h11 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 07/02/2019 | 23h13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 05/02/2019 | 19h09 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 05/02/2019 | 14h00 | GlobeNewswire Inc. | Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 31/01/2019 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 17/01/2019 | 15h00 | GlobeNewswire Inc. | Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 16/01/2019 | 15h00 | GlobeNewswire Inc. | Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 07/01/2019 | 14h30 | GlobeNewswire Inc. | Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 19/12/2018 | 00h00 | GlobeNewswire Inc. | Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1 | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 18/12/2018 | 23h29 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 10/12/2018 | 21h46 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 06/12/2018 | 13h30 | GlobeNewswire Inc. | Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 12/11/2018 | 13h30 | GlobeNewswire Inc. | Pain Therapeutics Appeals FDA Decision on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 01/11/2018 | 21h34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 31/10/2018 | 21h04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 30/10/2018 | 21h44 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 29/10/2018 | 21h09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |